S'abonner

Concordance of Phantom and Residual Limb Pain Phenotypes in Double Amputees: Evidence for the Contribution of Distinct and Common Individual Factors - 28/11/15

Doi : 10.1016/j.jpain.2015.08.013 
Fabian Streit , , Robin Bekrater-Bodmann , Martin Diers , §, Iris Reinhard , Josef Frank , Stefan Wüst , , Ze'ev Seltzer ∗∗, ††, Herta Flor , Marcella Rietschel
 Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany 
 Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany 
 Department of Biostatistics, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany 
 Institute of Psychobiology, University of Trier, Trier, Germany 
§ Department of Psychosomatic Medicine and Psychotherapy, LWL-University, Ruhr-University Bochum, Bochum, Germany 
 Institute of Experimental Psychology, University of Regensburg, Regensburg, Germany 
∗∗ Department of Anesthesia and Pain Management, Toronto General Hospital, Toronto, Canada 
†† Centre for the Study of Pain, Faculties of Dentistry and Medicine, University of Toronto, Toronto, Canada 

Address reprint requests to Fabian Streit, MSc, Central Institute of Mental Health, Square J5, D- 68159 Mannheim, Germany.

Abstract

Most, but not all, limb amputees develop phantom limb pain (PLP) or residual limb pain (RLP), and large interindividual differences in pain intensity and course are apparent. The present cross-sectional study of 122 double amputees investigated the possible role of genetic factors in PLP and RLP, assuming that strong individual predisposition results in high intraindividual concordance in pain phenotype. Intraindividual concordance was observed in 116 (95%) patients for development of PLP and in 110 patients (90%) for development of RLP. For both pain types, high intraindividual concordance was also observed for remission and current intensity. Moderate association for lifetime history and current intensity of PLP and RLP was observed both within and between limbs. The high intraindividual concordance in pain phenotypes suggests strong individual predisposition for PLP and RLP development. However, the finding of only moderate association between PLP and RLP suggests that susceptibility to these pain phenomena involves distinct, as well as common, risk factors. Genome-wide studies in large samples of single amputees may facilitate the dissection of these phenotypes and their underlying mechanisms.

Perspective

The observation of high intraindividual concordance for PLP and RLP in 122 double amputees suggests that individual factors contribute to post-amputation pain. The relatively low intraindividual association between PLP and RLP suggests that these factors are at least partially specific for each pain type.

Le texte complet de cet article est disponible en PDF.

Highlights

Phantom and residual limb pain were assessed in 122 double limb amputees.
High intraindividual concordance between limbs was observed for each type of pain.
Phantom and residual pain were only moderately associated.
Intraindividual concordance suggested a predisposition for both types of pain.
Medium association between both types of pain suggested some distinct risk factors.

Le texte complet de cet article est disponible en PDF.

Key words : Phantom limb pain, residual limb pain, concordance, heritability of pain, multiple amputations


Plan


 F.S., R.B.-B., Z.S., H.F., and M.R. contributed equally to this work.
 This research was supported by a European Research Council Advanced Grant for the project “Phantom Phenomena: A Window To The Mind And The Brain (PHANTOMIND),” which received research funding from the European Community's Seventh Framework Programme (FP7/2007–2013/ERC Grant Agreement No. 230249 [erc.europa.eu/]) awarded to H.F. and by funding from the German Research Foundation to the project “Genetische Grundlagen des Phantomschmerzes: Aufbau einer nationalen Forschungsressource (PHANTOMGENE)” (DFG; WU392/7-1: 2010–2014) awarded to S.W., H.F., and M.R. Z.S. is founding CEO and owner of Algogene Pain Genetics Inc, a board member of Newron Pharmaceuticals S.p.A., and received consultant fees from deCODE genetics. All other authors declare that they have no conflicts of interest regarding the material discussed in the article.
 Supplementary data accompanying this article are available online at www.jpain.org and www.sciencedirect.com.


© 2015  American Pain Society. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 16 - N° 12

P. 1377-1385 - décembre 2015 Retour au numéro
Article précédent Article précédent
  • Smaller Amygdala Volumes in Patients With Chronic Low Back Pain Compared With Healthy Control Individuals
  • Cui Ping Mao, Hua Juan Yang

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.